Abstract
Metformin (1,1-dimethylbiguanide) is an effective insulin sensitizer for diabetes management and an antiaging compound. Hydrogen sulfide (H(2)S) as a gasotransmitter also plays an important role in the regulation of diabetes and longevity. The interaction of these two molecules may find applications in various areas of cell biology. In this study, different preparations of hydrogen sulfide (H(2)S) were used to interact with metformin to form a metformin hydrosulfide (Metf(+)HS(-)), including H(2)S saturated tetrahydrofuran (THF) solution. H(2)S demonstrates greater stability in tetrahydrofuran (THF) than in acetone due to THF's moderate polarity, lower evaporation rate, and inert nature, which enhance its solubility and reduce undesired reactions. These properties facilitate controlled H(2)S release and improved reaction efficiency, making THF a more suitable solvent for H(2)S-related synthesis processes. Initially, metallic sodium was introduced into anhydrous ethanol under an inert atmosphere, and it reacted to form sodium ethoxide in situ. This freshly generated sodium ethoxide then acted as a strong base, deprotonating metformin hydrochloride to yield the free base form of metformin (1,1-dimethylbiguanide), which precipitated as a white solid after purification steps. This purified compound was subsequently converted into 1,1-dimethylbiguanide hydrosulfide (Metf(+)HS(-)) by reacting with a H(2)S in THF, yielding a slightly odorous, pale-yellow product. H(2)S release from the Metf(+)HS(-) salt was tested in two different solutions, H(2)O and Dulbecco's Modified Eagle Medium (DMEM), qualified and quantified with a lead acetate paper and a methylene blue spectrophotometry assay, respectively. The results show a higher release of H(2)S in DMEM than in H(2)O, likely due to the different solution buffering capacity and ionic strength. The dual functionality of Metf(+)HS(-), combining metformin's own therapeutic properties with the controlled release of H(2)S, makes it a novel candidate for treating different diseases like diabetes and cardiovascular disorders.